Location History:
- Maharashtra, IN (2019)
- Dhule, IN (2018 - 2022)
Company Filing History:
Years Active: 2018-2022
Title: **Shivnath Sahebrao Patil: Innovator in Pharmaceutical Processes**
Introduction
Shivnath Sahebrao Patil is a prominent inventor based in Maharashtra, India. With a total of four patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for synthesizing important compounds.
Latest Patents
Among his latest innovations, Patil has developed a process for the preparation of eribulin mesylate intermediate. This innovative process outlines improved methods for synthesizing an important eribulin intermediate, utilizing steps like de-protection and ketalization to yield the desired eribulin-diol compound. Moreover, he holds a patent for the preparation of hydroxocobalamin hydrochloride. This application presents an enhanced method for producing hydroxocobalamin hydrochloride from cyanocobalamin, ensuring improved yield and purity, as well as introducing a novel amorphous form of the compound.
Career Highlights
Throughout his career, Shivnath Sahebrao Patil has collaborated with various companies in the pharmaceutical sector. Notably, he has worked with Apicore US LLC and Rk Pharma Solutions LLC, contributing to both research and development efforts in these organizations. His background in chemical synthesis and process optimization has led him to become a recognized figure in his field.
Collaborations
Patil has collaborated with accomplished professionals including Ravishanker Kovi and Jayaraman Kannappan. Together, they have focused on innovative solutions within the pharmaceutical industry, fostering an environment of creativity and advancement in drug synthesis.
Conclusion
Shivnath Sahebrao Patil's contributions to pharmaceutical innovations through his patents reflect a commitment to improving drug development processes. His work is not only vital for advancing pharmaceutical manufacturing techniques but also demonstrates the potential impact of practical inventions on healthcare outcomes.